# EDGAR Filing Document

**Accession Number:** 0000277751
**File Stem:** 0001145549-25-057316
**Filing Date:** 2025-8
**Character Count:** 112156
**Document Hash:** 2188385a2f706f78356a8e317c692fcc
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001145549-25-057316.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0001145549-25-057316

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250829

**DATE AS OF CHANGE**: 20250829

**PERIOD START**: 20250930

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** JANUS INVESTMENT FUND
- **CENTRAL INDEX KEY:** 0000277751

**ORGANIZATION NAME:**
- **EIN:** 840592523
- **STATE OF INCORPORATION:** MA

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-01879
- **FILM NUMBER:** 251279178

**BUSINESS ADDRESS:**
- **STREET 1:** 151 DETROIT STREET
- **CITY:** DENVER
- **STATE:** CO
- **ZIP:** 80206
- **BUSINESS PHONE:** 303-333-3863

**MAIL ADDRESS:**
- **STREET 1:** 151 DETROIT STREET
- **CITY:** DENVER
- **STATE:** CO
- **ZIP:** 80206

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** JANUS FUND /MD/
- **DATE OF NAME CHANGE:** 19870701

## Series and Classes Contracts Data

### Janus Henderson Venture Fund (Series ID: S000010488)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000028950 | Class T      | JAVTX           |
| C000083533 | Class D      | JANVX           |
| C000100475 | Class A      | JVTAX           |
| C000100476 | Class C      | JVTCX           |
| C000100477 | Class I      | JVTIX           |
| C000100478 | Class S      | JVTSX           |
| C000114881 | Class N      | JVTNX           |

## Nport-Ex

**Janus Henderson Venture Fund**

**Schedule of Investments (unaudited)**

**June 30, 2025**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
|  | *Shares/Principal/* <br>*Contract Amounts*<br>| *Value* |
| Convertible Corporate Bonds – 0% |  |  |
| Biotechnology – 0% |  |  |
| &nbsp;&nbsp;&nbsp; Claris Biotherapeutics Inc, 8.0000%, 7/31/26<sup>¢</sup><sup>,</sup><sup>§</sup> (cost $221,444) | &nbsp;&nbsp;&nbsp;&nbsp; $221444 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $221444 |
| Common Stocks – 97.2% |  |  |
| Aerospace & Defense – 1.9% |  |  |
| &nbsp;&nbsp;&nbsp; Loar Holdings Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 254092 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 21895108 |
| &nbsp;&nbsp;&nbsp; Standardaero Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 763957 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 24179239 |
| &nbsp;&nbsp;&nbsp; Voyager Technologies Inc - Class A<sup>\*,#</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 299251 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 11745602 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 57819949 |
| Automobiles – 0.3% |  |  |
| &nbsp;&nbsp;&nbsp; Thor Industries Inc | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 110793 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9839526 |
| Banks – 1.6% |  |  |
| &nbsp;&nbsp;&nbsp; Bancorp Inc/The<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 865744 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 49321436 |
| Biotechnology – 11.1% |  |  |
| &nbsp;&nbsp;&nbsp; 89bio Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 1148158 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 11274912 |
| &nbsp;&nbsp;&nbsp; Akero Therapeutics Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 203002 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10832187 |
| &nbsp;&nbsp;&nbsp; Arcellx Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 146728 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9662039 |
| &nbsp;&nbsp;&nbsp; Ascendis Pharma A/S (ADR)<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 155121 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 26773885 |
| &nbsp;&nbsp;&nbsp; Avidity Biosciences Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 670867 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19052623 |
| &nbsp;&nbsp;&nbsp; Biohaven Ltd<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 530807 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7489687 |
| &nbsp;&nbsp;&nbsp; Bridgebio Pharma Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 538027 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 23232006 |
| &nbsp;&nbsp;&nbsp; Caris Life Sciences Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 644791 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17228816 |
| &nbsp;&nbsp;&nbsp; Centessa Pharmacuticals PLC (ADR)<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 498852 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6554915 |
| &nbsp;&nbsp;&nbsp; Crinetics Pharmaceuticals Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 289654 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8330449 |
| &nbsp;&nbsp;&nbsp; Disc Medicine Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 103473 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5479930 |
| &nbsp;&nbsp;&nbsp; Halozyme Therapeutics Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 345118 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17953038 |
| &nbsp;&nbsp;&nbsp; IDEAYA Biosciences Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 439542 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9239173 |
| &nbsp;&nbsp;&nbsp; Insmed Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 318482 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 32052028 |
| &nbsp;&nbsp;&nbsp; Janux Therapeutics Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 291055 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6723370 |
| &nbsp;&nbsp;&nbsp; Madrigal Pharmaceuticals Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 89583 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 27111399 |
| &nbsp;&nbsp;&nbsp; Mirum Pharmaceuticals Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 480836 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 24469744 |
| &nbsp;&nbsp;&nbsp; PTC Therapeutics Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 322303 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15741279 |
| &nbsp;&nbsp;&nbsp; Revolution Medicines Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 469585 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17276032 |
| &nbsp;&nbsp;&nbsp; Soleno Therapeutics Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 210080 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17600502 |
| &nbsp;&nbsp;&nbsp; Travere Therapeutics Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 245008 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3626118 |
| &nbsp;&nbsp;&nbsp; Vaxcyte Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 495273 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 16101325 |
| &nbsp;&nbsp;&nbsp; Xenon Pharmaceuticals Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 265441 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8308303 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp; 342113760 |
| Building Products – 2.6% |  |  |
| &nbsp;&nbsp;&nbsp; CSW Industrials Inc | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 81201 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 23290883 |
| &nbsp;&nbsp;&nbsp; Janus International Group Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 2039668 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 16602897 |
| &nbsp;&nbsp;&nbsp; Zurn Water Solutions Corp | &nbsp;&nbsp;&nbsp;&nbsp; 1081198 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 39539411 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 79433191 |
| Capital Markets – 2.5% |  |  |
| &nbsp;&nbsp;&nbsp; Hamilton Lane Inc | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 122993 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17479765 |
| &nbsp;&nbsp;&nbsp; LPL Financial Holdings Inc | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 160704 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 60259179 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 77738944 |
| Chemicals – 3.1% |  |  |
| &nbsp;&nbsp;&nbsp; Perimeter Solutions Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 2545253 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 35429922 |
| &nbsp;&nbsp;&nbsp; Sensient Technologies Corp | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 606593 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 59761542 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 95191464 |
| Commercial Services & Supplies – 3.9% |  |  |
| &nbsp;&nbsp;&nbsp; Brady Corp | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 184670 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12552020 |
| &nbsp;&nbsp;&nbsp; CECO Environmental Corp<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 874514 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 24757491 |
| &nbsp;&nbsp;&nbsp; Cimpress PLC<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 199517 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9377299 |
| &nbsp;&nbsp;&nbsp; Montrose Environmental Group Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 753767 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 16499960 |
| &nbsp;&nbsp;&nbsp; MSA Safety Inc | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 92042 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15419796 |
| &nbsp;&nbsp;&nbsp; Rentokil Initial PLC (ADR) | &nbsp;&nbsp;&nbsp;&nbsp; 1754424 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 42106176 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp; 120712742 |
| Construction & Engineering – 0.9% |  |  |
| &nbsp;&nbsp;&nbsp; Sterling Construction Co Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 126781 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 29252180 |
| Diversified Consumer Services – 2.7% |  |  |
| &nbsp;&nbsp;&nbsp; Stride Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 580358 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 84262178 |
| Diversified Financial Services – 3.7% |  |  |
| &nbsp;&nbsp;&nbsp; Euronet Worldwide Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 359369 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 36432829 |
| &nbsp;&nbsp;&nbsp; Repay Holdings Corp<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 616948 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2973690 |

---

------

---

| | | |
|:---|:---|:---|
|  | *Shares/Principal/*<br> *Contract Amounts*<br>| *Value* |
| Common Stocks – (continued) |  |  |
| Diversified Financial Services – (continued) |  |  |
| &nbsp;&nbsp;&nbsp; Shift4 Payments Inc - Class A<sup>\*,#</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 514610 | &nbsp;&nbsp;&nbsp;&nbsp; $51002997 |
| &nbsp;&nbsp;&nbsp; WEX Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 151711 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 22284829 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp; 112694345 |
| Diversified Telecommunication Services – 1.1% |  |  |
| &nbsp;&nbsp;&nbsp; AST SpaceMobile Inc<sup>\*,#</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 704711 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 32931145 |
| Electrical Equipment – 0.5% |  |  |
| &nbsp;&nbsp;&nbsp; EnerSys | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 173039 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 14841555 |
| Electronic Equipment, Instruments & Components – 4.9% |  |  |
| &nbsp;&nbsp;&nbsp; Arlo Technologies Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 908614 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15410093 |
| &nbsp;&nbsp;&nbsp; Bel Fuse Inc - Class B | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 272924 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 26661945 |
| &nbsp;&nbsp;&nbsp; Napco Security Technologies Inc | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 653368 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19398496 |
| &nbsp;&nbsp;&nbsp; Novanta Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 167390 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 21581593 |
| &nbsp;&nbsp;&nbsp; OSI Systems Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 300838 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 67646433 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp; 150698560 |
| Entertainment – 1.4% |  |  |
| &nbsp;&nbsp;&nbsp; Atlanta Braves Holdings Inc - Class C<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 714536 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 33418849 |
| &nbsp;&nbsp;&nbsp; Manchester United PLC<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 568938 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10132786 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 43551635 |
| Food & Staples Retailing – 1.6% |  |  |
| &nbsp;&nbsp;&nbsp; Casey's General Stores Inc | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 99471 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 50757067 |
| Food Products – 0.4% |  |  |
| &nbsp;&nbsp;&nbsp; Mama's Creations Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 1375242 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 11414509 |
| Health Care Equipment & Supplies – 5.3% |  |  |
| &nbsp;&nbsp;&nbsp; Beta Bionics Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 635906 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9258791 |
| &nbsp;&nbsp;&nbsp; Glaukos Corp<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 328064 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 33885731 |
| &nbsp;&nbsp;&nbsp; Globus Medical Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 629715 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 37165779 |
| &nbsp;&nbsp;&nbsp; ICU Medical Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 229343 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30307678 |
| &nbsp;&nbsp;&nbsp; Lantheus Holdings Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 410426 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 33597472 |
| &nbsp;&nbsp;&nbsp; STERIS PLC | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 76418 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18357132 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp; 162572583 |
| Health Care Providers & Services – 1.1% |  |  |
| &nbsp;&nbsp;&nbsp; HealthEquity Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 224083 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 23474935 |
| &nbsp;&nbsp;&nbsp; NeoGenomics Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 1308983 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9568666 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 33043601 |
| Health Care Technology – 2.0% |  |  |
| &nbsp;&nbsp;&nbsp; Doximity Inc - Class A<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 401450 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 24624943 |
| &nbsp;&nbsp;&nbsp; Simulations Plus Inc | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 759259 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13249070 |
| &nbsp;&nbsp;&nbsp; Waystar Holding Corp<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 577221 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 23591022 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 61465035 |
| Hotels, Restaurants & Leisure – 2.7% |  |  |
| &nbsp;&nbsp;&nbsp; Aramark | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 936571 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 39214228 |
| &nbsp;&nbsp;&nbsp; Inspired Entertainment Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 1275716 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10422600 |
| &nbsp;&nbsp;&nbsp; Monarch Casino & Resort Inc | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 235315 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20340628 |
| &nbsp;&nbsp;&nbsp; Portillo's Inc - Class A<sup>\*,#</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 1164718 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13592259 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 83569715 |
| Household Durables – 0.5% |  |  |
| &nbsp;&nbsp;&nbsp; Dream Finders Homes Inc - Class A<sup>\*,#</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 584195 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 14680820 |
| Insurance – 1.5% |  |  |
| &nbsp;&nbsp;&nbsp; BRP Group Inc - Class A<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 629344 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 26942217 |
| &nbsp;&nbsp;&nbsp; RLI Corp | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 247321 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17861522 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 44803739 |
| Interactive Media & Services – 0.5% |  |  |
| &nbsp;&nbsp;&nbsp; Ziff Davis Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 509596 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15425471 |
| Life Sciences Tools & Services – 0% |  |  |
| &nbsp;&nbsp;&nbsp; OmniAb Inc - 12.5 Earnout<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 104942 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 72158 |
| &nbsp;&nbsp;&nbsp; OmniAb Inc - 15 Earnout<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 104942 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 62252 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 134410 |
| Machinery – 7.5% |  |  |
| &nbsp;&nbsp;&nbsp; Alamo Group Inc | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 148435 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 32415235 |
| &nbsp;&nbsp;&nbsp; ATS Corp<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 870308 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 27759604 |
| &nbsp;&nbsp;&nbsp; EnPro Industries Inc | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 147326 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 28220295 |
| &nbsp;&nbsp;&nbsp; Gates Industrial Corp PLC<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 1389551 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 32001360 |
| &nbsp;&nbsp;&nbsp; ITT Inc | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 245239 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 38460832 |
| &nbsp;&nbsp;&nbsp; Kornit Digital Ltd<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 699477 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13926587 |
| &nbsp;&nbsp;&nbsp; SPX Technologies Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 341700 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 57296256 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp; 230080169 |
| Metals & Mining – 0.9% |  |  |
| &nbsp;&nbsp;&nbsp; Constellium SE<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 2177161 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 28956241 |

---

------

---

| | | |
|:---|:---|:---|
|  | *Shares/Principal/*<br> *Contract Amounts*<br>| *Value* |
| Common Stocks – (continued) |  |  |
| Oil, Gas & Consumable Fuels – 1.3% |  |  |
| &nbsp;&nbsp;&nbsp; California Resources Corp | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 237109 | &nbsp;&nbsp;&nbsp;&nbsp; $10828768 |
| &nbsp;&nbsp;&nbsp; Magnolia Oil & Gas Corp | &nbsp;&nbsp;&nbsp;&nbsp; 1290921 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 29019904 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 39848672 |
| Personal Products – 2.0% |  |  |
| &nbsp;&nbsp;&nbsp; BellRing Brands Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 384959 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 22300675 |
| &nbsp;&nbsp;&nbsp; Oddity Tech Ltd - Class A<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 516155 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 38954218 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 61254893 |
| Pharmaceuticals – 2.5% |  |  |
| &nbsp;&nbsp;&nbsp; Avadel Pharmaceuticals PLC<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 1480446 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13101947 |
| &nbsp;&nbsp;&nbsp; Edgewise Therapeutics Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 190678 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2499789 |
| &nbsp;&nbsp;&nbsp; Ligand Pharmaceuticals Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 285987 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 32511002 |
| &nbsp;&nbsp;&nbsp; Structure Therapeutics Inc (ADR)<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 262274 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5439563 |
| &nbsp;&nbsp;&nbsp; Verona Pharma PLC (ADR)<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 260197 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 24609432 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 78161733 |
| Professional Services – 9.5% |  |  |
| &nbsp;&nbsp;&nbsp; Alight Inc - Class A | &nbsp;&nbsp;&nbsp;&nbsp; 2778392 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15725699 |
| &nbsp;&nbsp;&nbsp; Asure Software Inc<sup>\*,</sup><sup>£</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 1612063 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15733735 |
| &nbsp;&nbsp;&nbsp; Broadridge Financial Solutions Inc | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 170715 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 41488866 |
| &nbsp;&nbsp;&nbsp; CACI International Inc - Class A<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 57748 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 27528472 |
| &nbsp;&nbsp;&nbsp; CBIZ Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 206867 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 14834433 |
| &nbsp;&nbsp;&nbsp; CRA International Inc | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 119955 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 22475968 |
| &nbsp;&nbsp;&nbsp; Innodata Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 519068 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 26586663 |
| &nbsp;&nbsp;&nbsp; Paylocity Holding Corp<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 211858 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 38386551 |
| &nbsp;&nbsp;&nbsp; SS&C Technologies Holdings Inc | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 857029 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 70962001 |
| &nbsp;&nbsp;&nbsp; UL Solutions Inc - Class A | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 244970 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17848514 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp; 291570902 |
| Real Estate Management & Development – 1.1% |  |  |
| &nbsp;&nbsp;&nbsp; Colliers International Group Inc - Subordinate Voting Shares | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 134204 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17518990 |
| &nbsp;&nbsp;&nbsp; FirstService Corp | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 102526 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17903090 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 35422080 |
| Semiconductor & Semiconductor Equipment – 2.2% |  |  |
| &nbsp;&nbsp;&nbsp; MACOM Technology Solutions Holdings Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 121973 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17477511 |
| &nbsp;&nbsp;&nbsp; Nova Ltd<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 47000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12934400 |
| &nbsp;&nbsp;&nbsp; ON Semiconductor Corp<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 380287 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19930842 |
| &nbsp;&nbsp;&nbsp; PDF Solutions Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 742419 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15872918 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 66215671 |
| Software – 8.6% |  |  |
| &nbsp;&nbsp;&nbsp; Alkami Technology Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 661762 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19945507 |
| &nbsp;&nbsp;&nbsp; Blackbaud Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 451740 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 29006225 |
| &nbsp;&nbsp;&nbsp; Clearwater Analytics Holdings Inc - Class A<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 699372 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15337228 |
| &nbsp;&nbsp;&nbsp; Computer Modelling Group Ltd | &nbsp;&nbsp;&nbsp;&nbsp; 1841300 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9750127 |
| &nbsp;&nbsp;&nbsp; Consensus Cloud Solutions Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 744357 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17164872 |
| &nbsp;&nbsp;&nbsp; Descartes Systems Group Inc/The<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 585574 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 59490637 |
| &nbsp;&nbsp;&nbsp; Kinaxis Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 132201 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19663151 |
| &nbsp;&nbsp;&nbsp; Nice Ltd (ADR)<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 107061 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18083674 |
| &nbsp;&nbsp;&nbsp; Procore Technologies Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 207418 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 14191540 |
| &nbsp;&nbsp;&nbsp; Tyler Technologies Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 58469 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 34662762 |
| &nbsp;&nbsp;&nbsp; Vertex Inc - Class A<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 750407 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 26515631 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp; 263811354 |
| Specialty Retail – 1.1% |  |  |
| &nbsp;&nbsp;&nbsp; Valvoline Inc<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 891322 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 33754364 |
| Textiles, Apparel & Luxury Goods – 1.1% |  |  |
| &nbsp;&nbsp;&nbsp; Gildan Activewear Inc | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 674833 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 33228777 |
| Trading Companies & Distributors – 1.6% |  |  |
| &nbsp;&nbsp;&nbsp; Core & Main Inc - Class A<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 833445 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 50298406 |
| Total Common Stocks (cost $1,814,334,269) |  | &nbsp;&nbsp; 2990872822 |
| Private Placements – 0.8% |  |  |
| Biotechnology – 0% |  |  |
| &nbsp;&nbsp;&nbsp; Claris Biotherapeutics Inc - Series A-3<sup>\*,</sup><sup>¢</sup><sup>,</sup><sup>§</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 5023916 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 481156 |
| Health Care Technology – 0.2% |  |  |
| &nbsp;&nbsp;&nbsp; Kardium Inc - Series 8 Class D Preferred shares<sup>\*,</sup><sup>¢</sup><sup>,</sup><sup>§</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 8991217 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5819475 |
| Professional Services – 0.4% |  |  |
| &nbsp;&nbsp;&nbsp; Apartment List Inc<sup>\*,</sup><sup>¢</sup><sup>,</sup><sup>§</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 2431401 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9628348 |
| &nbsp;&nbsp;&nbsp; IntelyCare Inc<sup>\*,</sup><sup>¢</sup><sup>,</sup><sup>§</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 384276 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 972218 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10600566 |

---

------

---

| | | |
|:---|:---|:---|
|  | *Shares/Principal/*<br> *Contract Amounts*<br>| *Value* |
| Private Placements – (continued) |  |  |
| Software – 0.2% |  |  |
| &nbsp;&nbsp;&nbsp; Loadsmart Inc - Series A<sup>\*,</sup><sup>¢</sup><sup>,</sup><sup>§</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 140312 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $1578510 |
| &nbsp;&nbsp;&nbsp; Loadsmart Inc - Series D<sup>\*,</sup><sup>¢</sup><sup>,</sup><sup>§</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 399891 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4498774 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6077284 |
| Total Private Placements (cost $39,589,565) |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 22978481 |
| Investment Companies – 2.1% |  |  |
| Money Markets – 2.1% |  |  |
| &nbsp;&nbsp;&nbsp; Janus Henderson Cash Liquidity Fund LLC, 4.4188%<sup>ºº,</sup><sup>£</sup> (cost $64,990,479) | &nbsp;&nbsp; 64977483 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 64990479 |
| Investments Purchased with Cash Collateral from Securities Lending – 2.2% |  |  |
| Investment Companies – 1.8% |  |  |
| &nbsp;&nbsp;&nbsp; Janus Henderson Cash Collateral Fund LLC, 4.2933%<sup>ºº,</sup><sup>£</sup> <br>| &nbsp;&nbsp; 54716853 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 54716853 |
| Time Deposits – 0.4% |  |  |
| &nbsp;&nbsp;&nbsp; Royal Bank of Canada, 4.3100%, 7/1/25 | $12571496 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12571496 |
| Total Investments Purchased with Cash Collateral from Securities Lending (cost $67,288,349) | Total Investments Purchased with Cash Collateral from Securities Lending (cost $67,288,349) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 67288349 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>OTC Purchased Options – Calls – 0%<br> Counterparty/Reference Asset |  |  |
| Morgan Stanley & Co International PLC: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Travere Therapeutics Inc, <br>Notional amount $2,541,160, premiums paid $717,706, unrealized depreciation <br> $(416527), exercise price $22.50, expires 3/20/26<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1717 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 301179 |
| Total Investments (total cost $1,987,141,812) – 102.3% |  | &nbsp;&nbsp; 3146652754 |
| Liabilities, net of Cash, Receivables and Other Assets – (2.3)% |  | &nbsp;&nbsp;&nbsp;&nbsp; (70416782) |
| Net Assets – 100% |  | $3076235972 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| ***Summary of Investments by Country - (Long Positions) (unaudited)*** |  |  |
| *Country* | *Value* | &nbsp;&nbsp; *% of* <br>*Investment* <br>*Securities*<br>|
| United States | $2739041504 | &nbsp;&nbsp;&nbsp;&nbsp; 87.0<br> %<br>|
| Canada | 191133851 | &nbsp;&nbsp;&nbsp;&nbsp;6.1 |
| Israel | 83898879 | &nbsp;&nbsp;&nbsp;&nbsp;2.7 |
| United Kingdom | 76848394 | &nbsp;&nbsp;&nbsp;&nbsp;2.4 |
| Netherlands | 28956241 | &nbsp;&nbsp;&nbsp;&nbsp;0.9 |
| Denmark | 26773885 | &nbsp;&nbsp;&nbsp;&nbsp;0.9 |
| Total | $3146652754 | &nbsp;&nbsp;&nbsp;&nbsp; 100.0<br> %<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| ***Schedule of Affiliated Investments - (% of Net Assets)*** | ***Schedule of Affiliated Investments - (% of Net Assets)*** | ***Schedule of Affiliated Investments - (% of Net Assets)*** | ***Schedule of Affiliated Investments - (% of Net Assets)*** | ***Schedule of Affiliated Investments - (% of Net Assets)*** | ***Schedule of Affiliated Investments - (% of Net Assets)*** | ***Schedule of Affiliated Investments - (% of Net Assets)*** | ***Schedule of Affiliated Investments - (% of Net Assets)*** | ***Schedule of Affiliated Investments - (% of Net Assets)*** |
| *Affiliate* | *Affiliated* <br>*Investments,* <br>*at Value at* <br>*9/30/24*<br>| *Purchases* | *Sales* <br>*Proceeds*<br>| *Realized* <br>*Gain/(Loss)*<br>| *Change in* <br>*Unrealized* <br>*Appreciation/* <br>*Depreciation*<br>| *Affiliated* <br>*Investments,* <br>*at Value at* <br>*6/30/25*<br>| *Ending* <br>*Shares*<br>| *Dividend* <br>*Income*<br>|
| Common Stocks - 0.5% | Common Stocks - 0.5% | Common Stocks - 0.5% | Common Stocks - 0.5% | Common Stocks - 0.5% | Common Stocks - 0.5% | Common Stocks - 0.5% | Common Stocks - 0.5% | Common Stocks - 0.5% |
| Professional Services - 0.5% | Professional Services - 0.5% | Professional Services - 0.5% | Professional Services - 0.5% | Professional Services - 0.5% | Professional Services - 0.5% | Professional Services - 0.5% | Professional Services - 0.5% | Professional Services - 0.5% |
| &nbsp;&nbsp;&nbsp; Asure Software Inc<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; Asure Software Inc<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; Asure Software Inc<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; Asure Software Inc<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; Asure Software Inc<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; Asure Software Inc<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; Asure Software Inc<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; Asure Software Inc<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; Asure Software Inc<sup>\*</sup>  |
|  | &nbsp;&nbsp; $14610845 | &nbsp;&nbsp; $212952 | &nbsp;&nbsp; $(223398) | &nbsp;&nbsp; $(14603) | &nbsp;&nbsp; $1147939 | &nbsp;&nbsp; $15733735 | &nbsp;&nbsp; 1612063 | &nbsp;&nbsp; $- |
| Investment Companies - 2.1% | Investment Companies - 2.1% | Investment Companies - 2.1% | Investment Companies - 2.1% | Investment Companies - 2.1% | Investment Companies - 2.1% | Investment Companies - 2.1% | Investment Companies - 2.1% | Investment Companies - 2.1% |
| Money Markets - 2.1% | Money Markets - 2.1% | Money Markets - 2.1% | Money Markets - 2.1% | Money Markets - 2.1% | Money Markets - 2.1% | Money Markets - 2.1% | Money Markets - 2.1% | Money Markets - 2.1% |
| &nbsp;&nbsp;&nbsp; Janus Henderson Cash Liquidity Fund LLC, 4.4188%<sup>ºº</sup>  | &nbsp;&nbsp;&nbsp; Janus Henderson Cash Liquidity Fund LLC, 4.4188%<sup>ºº</sup>  | &nbsp;&nbsp;&nbsp; Janus Henderson Cash Liquidity Fund LLC, 4.4188%<sup>ºº</sup>  | &nbsp;&nbsp;&nbsp; Janus Henderson Cash Liquidity Fund LLC, 4.4188%<sup>ºº</sup>  | &nbsp;&nbsp;&nbsp; Janus Henderson Cash Liquidity Fund LLC, 4.4188%<sup>ºº</sup>  | &nbsp;&nbsp;&nbsp; Janus Henderson Cash Liquidity Fund LLC, 4.4188%<sup>ºº</sup>  | &nbsp;&nbsp;&nbsp; Janus Henderson Cash Liquidity Fund LLC, 4.4188%<sup>ºº</sup>  | &nbsp;&nbsp;&nbsp; Janus Henderson Cash Liquidity Fund LLC, 4.4188%<sup>ºº</sup>  | &nbsp;&nbsp;&nbsp; Janus Henderson Cash Liquidity Fund LLC, 4.4188%<sup>ºº</sup>  |
|  | &nbsp;&nbsp; 32581349 | &nbsp;&nbsp; 471061379 | &nbsp;&nbsp; (438652249) | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; 64990479 | &nbsp;&nbsp; 64977483 | &nbsp;&nbsp; 1426140 |
| Investments Purchased with Cash Collateral from Securities Lending - 1.8% | Investments Purchased with Cash Collateral from Securities Lending - 1.8% | Investments Purchased with Cash Collateral from Securities Lending - 1.8% | Investments Purchased with Cash Collateral from Securities Lending - 1.8% | Investments Purchased with Cash Collateral from Securities Lending - 1.8% | Investments Purchased with Cash Collateral from Securities Lending - 1.8% | Investments Purchased with Cash Collateral from Securities Lending - 1.8% | Investments Purchased with Cash Collateral from Securities Lending - 1.8% | Investments Purchased with Cash Collateral from Securities Lending - 1.8% |
| Investment Companies - 1.8% | Investment Companies - 1.8% | Investment Companies - 1.8% | Investment Companies - 1.8% | Investment Companies - 1.8% | Investment Companies - 1.8% | Investment Companies - 1.8% | Investment Companies - 1.8% | Investment Companies - 1.8% |
| &nbsp;&nbsp;&nbsp; Janus Henderson Cash Collateral Fund LLC, 4.2933%<sup>ºº</sup>  | &nbsp;&nbsp;&nbsp; Janus Henderson Cash Collateral Fund LLC, 4.2933%<sup>ºº</sup>  | &nbsp;&nbsp;&nbsp; Janus Henderson Cash Collateral Fund LLC, 4.2933%<sup>ºº</sup>  | &nbsp;&nbsp;&nbsp; Janus Henderson Cash Collateral Fund LLC, 4.2933%<sup>ºº</sup>  | &nbsp;&nbsp;&nbsp; Janus Henderson Cash Collateral Fund LLC, 4.2933%<sup>ºº</sup>  | &nbsp;&nbsp;&nbsp; Janus Henderson Cash Collateral Fund LLC, 4.2933%<sup>ºº</sup>  | &nbsp;&nbsp;&nbsp; Janus Henderson Cash Collateral Fund LLC, 4.2933%<sup>ºº</sup>  | &nbsp;&nbsp;&nbsp; Janus Henderson Cash Collateral Fund LLC, 4.2933%<sup>ºº</sup>  | &nbsp;&nbsp;&nbsp; Janus Henderson Cash Collateral Fund LLC, 4.2933%<sup>ºº</sup>  |
|  | &nbsp;&nbsp; 20163878 | &nbsp;&nbsp; 241860601 | &nbsp;&nbsp; (207307626) | &nbsp;&nbsp; - | &nbsp;&nbsp; - | &nbsp;&nbsp; 54716853 | &nbsp;&nbsp; 54716853 | &nbsp;&nbsp; 185673 <br><sup>∆</sup><br>|
| Total Affiliated Investments - 4.4% | Total Affiliated Investments - 4.4% | Total Affiliated Investments - 4.4% | Total Affiliated Investments - 4.4% | Total Affiliated Investments - 4.4% | Total Affiliated Investments - 4.4% | Total Affiliated Investments - 4.4% | Total Affiliated Investments - 4.4% | Total Affiliated Investments - 4.4% |
|  | &nbsp;&nbsp; $67356072 | &nbsp;&nbsp; $713134932 | &nbsp;&nbsp; $(646183273) | &nbsp;&nbsp; $(14603) | &nbsp;&nbsp; $1147939 | &nbsp;&nbsp; $135441067 | &nbsp;&nbsp; 121306399 | &nbsp;&nbsp; $1611813 |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***Schedule of Forward Foreign Currency Exchange Contracts*** | ***Schedule of Forward Foreign Currency Exchange Contracts*** | ***Schedule of Forward Foreign Currency Exchange Contracts*** | ***Schedule of Forward Foreign Currency Exchange Contracts*** | ***Schedule of Forward Foreign Currency Exchange Contracts*** |
| *Counterparty/* <br>*Foreign Currency*<br>| *Settlement* <br>*Date*<br>| &nbsp;&nbsp; *Foreign Currency* <br>*Amount (Sold)/* <br>*Purchased*<br>| &nbsp;&nbsp; *USD Currency* <br>*Amount (Sold)/* <br>*Purchased*<br>| &nbsp;&nbsp; *Market Value and* <br>*Unrealized* <br>*Appreciation/* <br>*(Depreciation)*<br>|
| Bank of America, National Association: | Bank of America, National Association: | Bank of America, National Association: | Bank of America, National Association: | Bank of America, National Association: |
| &nbsp;&nbsp;&nbsp; British Pound | 9/18/25 | &nbsp;&nbsp;&nbsp; 20655000 | &nbsp;&nbsp;&nbsp; $(27817450) | &nbsp;&nbsp;&nbsp; $543338 |
| &nbsp;&nbsp;&nbsp; Canadian Dollar | 9/18/25 | &nbsp;&nbsp;&nbsp; (5057000) | &nbsp;&nbsp;&nbsp; 3709896 | &nbsp;&nbsp;&nbsp; (18920) |
|  |  |  |  | &nbsp;&nbsp;&nbsp; 524418 |
| Barclays Capital, Inc.: | Barclays Capital, Inc.: | Barclays Capital, Inc.: | Barclays Capital, Inc.: | Barclays Capital, Inc.: |
| &nbsp;&nbsp;&nbsp; British Pound | 9/18/25 | &nbsp;&nbsp;&nbsp; 58100 | &nbsp;&nbsp;&nbsp; (78308) | &nbsp;&nbsp;&nbsp; 1468 |
| &nbsp;&nbsp;&nbsp; Canadian Dollar | 9/18/25 | &nbsp;&nbsp;&nbsp; (10595900) | &nbsp;&nbsp;&nbsp; 7794033 | &nbsp;&nbsp;&nbsp; (18931) |
|  |  |  |  | &nbsp;&nbsp;&nbsp; (17463) |
| Citibank, National Association: | Citibank, National Association: | Citibank, National Association: | Citibank, National Association: | Citibank, National Association: |
| &nbsp;&nbsp;&nbsp; British Pound | 9/18/25 | &nbsp;&nbsp;&nbsp; (27874800) | &nbsp;&nbsp;&nbsp; 37553715 | &nbsp;&nbsp;&nbsp; (720374) |
| &nbsp;&nbsp;&nbsp; Canadian Dollar | 9/18/25 | &nbsp;&nbsp;&nbsp; (12243900) | &nbsp;&nbsp;&nbsp; 8983846 | &nbsp;&nbsp;&nbsp; (44282) |
|  |  |  |  | &nbsp;&nbsp;&nbsp; (764656) |
| Goldman Sachs & Co. LLC: | Goldman Sachs & Co. LLC: | Goldman Sachs & Co. LLC: | Goldman Sachs & Co. LLC: | Goldman Sachs & Co. LLC: |
| &nbsp;&nbsp;&nbsp; British Pound | 9/18/25 | &nbsp;&nbsp;&nbsp; (14321000) | &nbsp;&nbsp;&nbsp; 19286320 | &nbsp;&nbsp;&nbsp; (377435) |
| &nbsp;&nbsp;&nbsp; Canadian Dollar | 9/18/25 | &nbsp;&nbsp;&nbsp; (8586000) | &nbsp;&nbsp;&nbsp; 6306618 | &nbsp;&nbsp;&nbsp; (24331) |
|  |  |  |  | &nbsp;&nbsp;&nbsp; (401766) |
| HSBC Securities (USA), Inc.: | HSBC Securities (USA), Inc.: | HSBC Securities (USA), Inc.: | HSBC Securities (USA), Inc.: | HSBC Securities (USA), Inc.: |
| &nbsp;&nbsp;&nbsp; British Pound | 9/18/25 | &nbsp;&nbsp;&nbsp; (13376400) | &nbsp;&nbsp;&nbsp; 18006856 | &nbsp;&nbsp;&nbsp; (359895) |
| &nbsp;&nbsp;&nbsp; Canadian Dollar | 9/18/25 | &nbsp;&nbsp;&nbsp; (66035700) | &nbsp;&nbsp;&nbsp; 48464008 | &nbsp;&nbsp;&nbsp; (227894) |
|  |  |  |  | &nbsp;&nbsp;&nbsp; (587789) |
| JPMorgan Chase Bank, National Association: | JPMorgan Chase Bank, National Association: | JPMorgan Chase Bank, National Association: | JPMorgan Chase Bank, National Association: | JPMorgan Chase Bank, National Association: |
| &nbsp;&nbsp;&nbsp; British Pound | 9/18/25 | &nbsp;&nbsp;&nbsp; (14103800) | &nbsp;&nbsp;&nbsp; 18994546 | &nbsp;&nbsp;&nbsp; (370977) |
| &nbsp;&nbsp;&nbsp; Canadian Dollar | 9/18/25 | &nbsp;&nbsp;&nbsp; (57100500) | &nbsp;&nbsp;&nbsp; 41883824 | &nbsp;&nbsp;&nbsp; (219643) |
|  |  |  |  | &nbsp;&nbsp;&nbsp; (590620) |
| Morgan Stanley & Co. International PLC: | Morgan Stanley & Co. International PLC: | Morgan Stanley & Co. International PLC: | Morgan Stanley & Co. International PLC: | Morgan Stanley & Co. International PLC: |
| &nbsp;&nbsp;&nbsp; British Pound | 9/18/25 | &nbsp;&nbsp;&nbsp; 11221000 | &nbsp;&nbsp;&nbsp; (15112174) | &nbsp;&nbsp;&nbsp; 295060 |
| &nbsp;&nbsp;&nbsp; Canadian Dollar | 9/18/25 | &nbsp;&nbsp;&nbsp; 16665000 | &nbsp;&nbsp;&nbsp; (12229469) | &nbsp;&nbsp;&nbsp; 58589 |
|  |  |  |  | &nbsp;&nbsp;&nbsp; 353649 |
| State Street Bank and Trust Company: | State Street Bank and Trust Company: | State Street Bank and Trust Company: | State Street Bank and Trust Company: | State Street Bank and Trust Company: |
| &nbsp;&nbsp;&nbsp; British Pound | 9/18/25 | &nbsp;&nbsp;&nbsp; 1726000 | &nbsp;&nbsp;&nbsp; (2368439) | &nbsp;&nbsp;&nbsp; 1482 |
| &nbsp;&nbsp;&nbsp; British Pound | 9/18/25 | &nbsp;&nbsp;&nbsp; (16795832) | &nbsp;&nbsp;&nbsp; 22601160 | &nbsp;&nbsp;&nbsp; (460715) |
| &nbsp;&nbsp;&nbsp; Canadian Dollar | 9/18/25 | &nbsp;&nbsp;&nbsp; (14498500) | &nbsp;&nbsp;&nbsp; 10641140 | &nbsp;&nbsp;&nbsp; (49434) |
|  |  |  |  | &nbsp;&nbsp;&nbsp; (508667) |
| Total |  |  |  | &nbsp;&nbsp;&nbsp; $(1992894) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| ***Schedule of OTC Written Options*** | ***Schedule of OTC Written Options*** | ***Schedule of OTC Written Options*** | ***Schedule of OTC Written Options*** | ***Schedule of OTC Written Options*** | ***Schedule of OTC Written Options*** | ***Schedule of OTC Written Options*** | ***Schedule of OTC Written Options*** | ***Schedule of OTC Written Options*** |
| *Counterparty/* <br>*Reference Asset*<br>| *Number of* <br>*Contracts*<br>| &nbsp;&nbsp; *Exercise* <br>*Price*<br>|  | &nbsp;&nbsp; *Expiration* <br>*Date*<br>| &nbsp;&nbsp; *Notional* <br>*Amount*<br>| &nbsp;&nbsp; *Premiums* <br>*Received*<br>| &nbsp;&nbsp; *Unrealized* <br>*Appreciation/* <br>*(Depreciation)*<br>| &nbsp;&nbsp; *Options* <br>*Written,* <br>*at Value*<br>|
| *Written Call Options:* | *Written Call Options:* | *Written Call Options:* | *Written Call Options:* |  |  |  |  |  |
| *Morgan Stanley & Co International PLC:* | *Morgan Stanley & Co International PLC:* | *Morgan Stanley & Co International PLC:* | *Morgan Stanley & Co International PLC:* |  |  |  |  |  |
| Ast Spacemobile Inc | 2000 | &nbsp;&nbsp;&nbsp;&nbsp;55.00 | USD | &nbsp;&nbsp;&nbsp; 1/16/26 | &nbsp;&nbsp;&nbsp; $(9346000) | &nbsp;&nbsp;&nbsp; $1129600 | &nbsp;&nbsp;&nbsp; $(916695) | &nbsp;&nbsp;&nbsp; $(2046295) |
| *Goldman Sachs & Co LLC:* | *Goldman Sachs & Co LLC:* | *Goldman Sachs & Co LLC:* | *Goldman Sachs & Co LLC:* |  |  |  |  |  |
| Ast Spacemobile Inc | 1524 | &nbsp;&nbsp;&nbsp;&nbsp;60.00 | USD | &nbsp;&nbsp;&nbsp; 6/18/26 | &nbsp;&nbsp;&nbsp; (7121652) | &nbsp;&nbsp;&nbsp; 1170610 | &nbsp;&nbsp;&nbsp; (789529) | &nbsp;&nbsp;&nbsp; (1960139) |
| Total OTC Written Options | Total OTC Written Options |  |  |  |  | &nbsp;&nbsp;&nbsp; $2300210 | &nbsp;&nbsp;&nbsp; $(1706224) | &nbsp;&nbsp;&nbsp; $(4006434) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| **Average Ending Monthly Value of Derivative Instruments During the Period Ended June 30, 2025** | **Average Ending Monthly Value of Derivative Instruments During the Period Ended June 30, 2025** |
| Forward foreign currency exchange contracts: |  |
| Average amounts purchased - in USD | $100024567 |
| Average amounts sold - in USD | 280915574 |
| Options: |  |
| Average value of option contracts purchased | 626748 |
| Average value of option contracts written | 807675 |

---

------

**Notes to Schedule of Investments (unaudited)** 

---

| | |
|:---|:---|
| ADR | American Depositary Receipt |
| LLC | Limited Liability Company |
| OTC | Over-the-Counter |
| PLC | Public Limited Company |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| Non-income producing security. |
| Rate shown is the 7-day yield as of June 30, 2025. |
| Loaned security; a portion of the security is on loan at June 30, 2025. |
| &nbsp;&nbsp; Security is valued using significant unobservable inputs. The total value of Level 3 securities as of the period ended June 30, 2025 is <br> $23,199,925, which represents 0.8% of net assets.<br>|
| £&nbsp;&nbsp; The Fund may invest in certain securities that are considered affiliated companies. As defined by the Investment Company Act of 1940, as <br> amended, an affiliated company is one in which the Fund owns 5% or more of the outstanding voting securities, or a company which is <br> under common ownership or control.<br>|
| Net of income paid to the securities lending agent and rebates paid to the borrowing counterparties. |
| Schedule of Restricted Securities (as of June 30, 2025) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | *Acquisition* <br>*Date*<br>| *Cost* | *Value* | &nbsp;&nbsp; *Value as a* <br>*% of Net* <br>*Assets*<br>|
| Apartment List Inc | 11/2/2020 | &nbsp;&nbsp;&nbsp; $8881908 | $9628348 | &nbsp;&nbsp;&nbsp;&nbsp; 0.3<br> %<br>|
| Claris Biotherapeutics Inc, 8.0000%, 7/31/26 | 2/26/2025 | &nbsp;&nbsp;&nbsp; 221444 | 221444 | &nbsp;&nbsp;&nbsp;&nbsp;0.0 |
| Claris Biotherapeutics Inc - Series A-3 | 12/28/2023 | &nbsp;&nbsp;&nbsp; 4811555 | 481156 | &nbsp;&nbsp;&nbsp;&nbsp;0.0 |
| IntelyCare Inc | 3/29/2022 | &nbsp;&nbsp;&nbsp; 9412879 | 972218 | &nbsp;&nbsp;&nbsp;&nbsp;0.1 |
| Kardium Inc - Series 8 Class D Preferred shares | 6/6/2025 | &nbsp;&nbsp;&nbsp; 5819475 | 5819475 | &nbsp;&nbsp;&nbsp;&nbsp;0.2 |
| Loadsmart Inc - Series A | 1/4/2022 | &nbsp;&nbsp;&nbsp; 2665928 | 1578510 | &nbsp;&nbsp;&nbsp;&nbsp;0.1 |
| Loadsmart Inc - Series D | 1/4/2022 | &nbsp;&nbsp;&nbsp; 7997820 | 4498774 | &nbsp;&nbsp;&nbsp;&nbsp;0.1 |
| Total |  | &nbsp;&nbsp;&nbsp; $39811009 | $23199925 | &nbsp;&nbsp;&nbsp; 0.8% |

---

The Fund has registration rights for certain restricted securities held as of June 30, 2025. The issuer incurs all registration costs.

------

The following is a summary of the inputs that were used to value the Fund's investments in securities and other financial

instruments as of June 30, 2025.

---

| | | | |
|:---|:---|:---|:---|
| **Valuation Inputs Summary** | **Valuation Inputs Summary** | **Valuation Inputs Summary** | **Valuation Inputs Summary** |
|  | ***Level 1 -*** <br>***Quoted Prices***<br>| &nbsp;&nbsp; ***Level 2 -*** <br>***Other Significant*** <br>***Observable Inputs***<br>| &nbsp;&nbsp; ***Level 3 -*** <br>***Significant*** <br>***Unobservable Inputs***<br>|
| **Assets** |  |  |  |
| **Investments In Securities:** |  |  |  |
| *Convertible Corporate Bonds* | $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $221444 |
| *Common Stocks* |  |  |  |
| Life Sciences Tools & Services | - | &nbsp;&nbsp;&nbsp; 134410 | &nbsp;&nbsp;&nbsp; - |
| All Other | 2990738412 | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; - |
| *Private Placements* | - | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 22978481 |
| *Investment Companies* | - | &nbsp;&nbsp;&nbsp; 64990479 | &nbsp;&nbsp;&nbsp; - |
| *Investments Purchased with Cash Collateral from Securities Lending* | - | &nbsp;&nbsp;&nbsp; 67288349 | &nbsp;&nbsp;&nbsp; - |
| *OTC Purchased Options – Calls* | - | &nbsp;&nbsp;&nbsp; 301179 | &nbsp;&nbsp;&nbsp; - |
| Total Investments in Securities | $2990738412 | &nbsp;&nbsp;&nbsp; $132714417 | &nbsp;&nbsp;&nbsp; $23199925 |
| **Other Financial Instruments**<sup>(a)</sup>**:** |  |  |  |
| *Forward Foreign Currency Exchange Contracts* | - | &nbsp;&nbsp;&nbsp; 899937 | &nbsp;&nbsp;&nbsp; - |
| **Total Assets** | $2990738412 | &nbsp;&nbsp;&nbsp; $133614354 | &nbsp;&nbsp;&nbsp; $23199925 |
| **Liabilities** |  |  |  |
| **Other Financial Instruments**<sup>(a)</sup>**:** |  |  |  |
| *Forward Foreign Currency Exchange Contracts* | $- | &nbsp;&nbsp;&nbsp; $2892831 | &nbsp;&nbsp;&nbsp; $- |
| *OTC Options Written, at Value* | - | &nbsp;&nbsp;&nbsp; 4006434 | &nbsp;&nbsp;&nbsp; - |
| **Total Liabilities** | $- | &nbsp;&nbsp;&nbsp; $6899265 | &nbsp;&nbsp;&nbsp; $- |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;(a) Other financial instruments may include forward foreign currency exchange contracts,
 futures, written options, written swaptions, and swap contracts. Forward foreign currency exchange contracts, futures contracts, and centrally
 cleared swap contracts are reported at their unrealized appreciation/(depreciation) at measurement date, which represents the change in the
 contract's value from trade date. Written options, written swaptions, and OTC swaps are reported at their market value at measurement date.

------

**Investment Valuation**

Fund holdings are valued in accordance with policies and procedures established by the Adviser pursuant to Rule 2a-5 under the 1940 Act and approved by and subject to the oversight of the Trustees (the "Valuation Procedures"). Equity securities traded on a domestic securities exchange are generally valued at readily available market quotations, which are (i) the official close prices or (ii) last sale prices on the primary market or exchange in which the securities trade. If such price is lacking for the trading period immediately preceding the time of determination, such securities are generally valued at their current bid price. Equity securities that are traded on a foreign exchange are generally valued at the closing prices on such markets. In the event that there is no current trading volume on a particular security in such foreign exchange, the bid price from the primary exchange is generally used to value the security. Foreign securities and currencies are converted to U.S. dollars using the current spot USD dollar exchange rate in effect at the close of the New York Stock Exchange ("NYSE"). The Adviser will determine the market value of individual securities held by it by using prices provided by one or more Adviser-approved professional pricing services or, as needed, by obtaining market quotations from independent broker-dealers. Most debt securities are valued in accordance with the evaluated bid price supplied by the pricing service that is intended to reflect market value. The evaluated bid price supplied by the pricing service is an evaluation that may consider factors such as security prices, yields, maturities, and ratings. Certain short-term securities maturing within 60 days or less may be evaluated and valued on an amortized cost basis provided that the amortized cost determined approximates market value. Securities for which market quotations or evaluated prices are not readily available or deemed unreliable are valued at fair value determined in good faith by the Adviser pursuant to the Valuation Procedures. Circumstances in which fair valuation may be utilized include, but are not limited to: (i) a significant event that may affect the securities of a single issuer, such as a merger, bankruptcy, or significant issuer-specific development; (ii) an event that may affect an entire market, such as a natural disaster or significant governmental action; (iii) a nonsignificant event such as a market closing early or not opening, or a security trading halt; and (iv) pricing of a non-valued security and a restricted or nonpublic security. Special valuation considerations may apply with respect to "odd-lot" fixed-income transactions which, due to their small size, may receive evaluated prices by pricing services which reflect a large block trade and not what actually could be obtained for the odd-lot position. The value of the securities of other mutual funds held by the Fund, if any, will be calculated using the NAV of such mutual funds, and the prospectuses for such mutual funds explain the circumstances under which they use fair valuation and the effects of using fair valuation. The value of the securities of any cash management pooled investment vehicles that

operate as money market funds held by the Fund, if any, will be calculated using the NAV of such funds.

**Valuation Inputs Summary**

FASB ASC 820, *Fair Value Measurements and Disclosures* ("ASC 820"), defines fair value, establishes a framework for measuring fair value, and expands disclosure requirements regarding fair value measurements. This standard emphasizes that fair value is a market-based measurement that should be determined based on the assumptions that market participants would use in pricing an asset or liability and establishes a hierarchy that prioritizes inputs to valuation techniques used to measure fair value. These inputs are summarized into three broad levels:

Level 1 – Unadjusted quoted prices in active markets the Fund has the ability to access for identical assets or liabilities.

Level 2 – Observable inputs other than unadjusted quoted prices included in Level 1 that are observable for the asset or liability either directly or indirectly. These inputs may include quoted prices for the identical instrument on an inactive market, prices for similar instruments, interest rates, prepayment speeds, credit risk, yield curves, default

rates and similar data.

Assets or liabilities categorized as Level 2 in the hierarchy generally include: debt securities fair valued in accordance with the evaluated bid or ask prices supplied by a pricing service; securities traded on OTC markets and listed securities for which no sales are reported that are fair valued at the latest bid price (or yield equivalent thereof) obtained from one or more dealers transacting in a market for such securities or by a pricing service approved by the Fund's Trustees; certain short-term debt securities with maturities of 60 days or less that are fair valued at amortized cost; and equity securities of foreign issuers whose fair value is determined by using systematic fair valuation models provided by independent third parties in order to adjust for stale pricing which may occur between the close of certain foreign exchanges and the close of the NYSE. Other securities that may be categorized as Level 2 in the hierarchy include, but are not limited to, preferred stocks, bank loans, swaps,

investments in unregistered investment companies, options, and forward contracts.

Level 3 – Unobservable inputs for the asset or liability to the extent that relevant observable inputs are not available, representing the Fund's own assumptions about the assumptions that a market participant would use in valuing the asset or liability, and that would be based on the best information available.

There have been no significant changes in valuation techniques used in valuing any such positions held by the Fund since the beginning of the fiscal period.

------

The inputs or methodology used for fair valuing securities are not necessarily an indication of the risk associated with investing in those securities. The summary of inputs used as of June 30, 2025 to fair value the Fund's investments in securities and other financial instruments is included in the "Valuation Inputs Summary" in the Notes to Schedule of

Investments.

The Fund's management has determined the Fund did not hold a significant amount of Level 3 securities as of June 30, 2025.

------

For additional information on the Fund, please refer to the Fund's most recent semiannual or annual financial

statements.

125-35-70253 08-25

------

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** JANUS INVESTMENT FUND

- **b. Investment Company Act file number:** 811-01879

- **c. CIK number of Registrant:** 0000277751

- **d. LEI of Registrant:** W6UYDZFUOFJ4HQQ32382

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 151 Detroit Street

  - **City:** Denver

  - **State:** CO

  - **Foreign country:** US

  - **Zip / Postal Code:** 80206

  - **Telephone number:** 303-333-3863

**Item A.2. Information about the Series.**

- **a. Name of Series:** Janus Henderson Venture Fund

- **b. EDGAR series identifier (if any):** S000010488

- **c. LEI of Series:** M8SXC17QOUZM03NWSY64

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-09-30

- **b. Date as of which information is reported:** 2025-06-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $3084412573.74

**Total Liabilities:** $8176601.45

**Net Assets:** $3076235972.29

**Cash Not Reported:** $4385767.24

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000028950 | 0.47%                | 3.53%                | 4.20%                |
| Class ID C000083533 | 0.48%                | 3.53%                | 4.22%                |
| Class ID C000100475 | 0.46%                | 3.52%                | 4.19%                |
| Class ID C000100476 | 0.38%                | 3.46%                | 4.12%                |
| Class ID C000100477 | 0.48%                | 3.55%                | 4.22%                |
| Class ID C000100478 | 0.44%                | 3.51%                | 4.19%                |
| Class ID C000114881 | 0.50%                | 3.54%                | 4.23%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-36250433.00            | $55237133.00                               |
| Month 2  | $-1831719.00             | $105370105.00                              |
| Month 3  | $-43073952.00            | $173788760.00                              |

**Designated Index Information**

- **Index Name:** Russell 2000 Growth TR Index

- **Index Identifier:** RUSSELL.MC.RUO

### Schedule of Portfolio Investments

| Name                                          | Title                                                 | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Alamo Group Inc                               | Alamo Group Inc COM USD0.10                           | CUSIP: 011311107<br>LEI: 54930080C93RVZRSDV26 | Long             | EC               | CORP              | US        |    148435 | NS      | $32415235.30  | 1.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Alight Inc                                    | Alight Inc COM CL A                                   | CUSIP: 01626W101<br>LEI: 549300600ESCO1HTVN74 | Long             | EC               | CORP              | US        |   2778392 | NS      | $15725698.72  | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Alkami Technology Inc.                        | Alkami Technology Inc. COM                            | CUSIP: 01644J108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    661762 | NS      | $19945506.68  | 0.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Aramark                                       | Aramark COM USD0.01                                   | CUSIP: 03852U106<br>LEI: 549300MR6PG2DWZUIL39 | Long             | EC               | CORP              | US        |    936571 | NS      | $39214227.77  | 1.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcellx Inc                                   | Arcellx Inc COMMON STOCK                              | CUSIP: 03940C100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    146728 | NS      | $9662038.80   | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Arlo Technologies Inc                         | Arlo Technologies Inc COM USD0.001                    | CUSIP: 04206A101<br>LEI: 549300T4EUX2OQ75HV52 | Long             | EC               | CORP              | US        |    908614 | NS      | $15410093.44  | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Ascendis Pharma A/S                           | Ascendis Pharma A/S SPON ADR EACH REP 1 ORD SHS       | CUSIP: 04351P101<br>LEI: 549300B66JN3W3J8GH73 | Long             |  | CORP              | US        |    155121 | NS      | $26773884.60  | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Asure Software Inc                            | Asure Software Inc COM USD0.01                        | CUSIP: 04649U102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1612063 | NS      | $15733734.88  | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Atlanta Braves Holdings Inc                   | Atlanta Braves Holdings Inc COM SER C                 | CUSIP: 047726302<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    714536 | NS      | $33418848.72  | 1.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Avidity Biosciences Inc.                      | Avidity Biosciences Inc. COM                          | CUSIP: 05370A108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    670867 | NS      | $19052622.80  | 0.62%             |  |  |  | No            |                  1 | On Loan: No      |
| The Baldwin Insurance Group Inc               | The Baldwin Insurance Group Inc COM CL A              | CUSIP: 05589G102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    629344 | NS      | $26942216.64  | 0.88%             |  |  |  | No            |                  1 | On Loan: No      |
| Bancorp Inc                                   | Bancorp Inc COM NPV                                   | CUSIP: 05969A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    865744 | NS      | $49321435.68  | 1.60%             |  |  |  | No            |                  1 | On Loan: No      |
| BEL Fuse Inc                                  | BEL Fuse Inc CLASS'B'SHS USD0.1                       | CUSIP: 077347300<br>LEI: 2549009L4XYDBRRY6X39 | Long             | EC               | CORP              | US        |    272924 | NS      | $26661945.56  | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| BellRing Intermediate Holdings Inc.           | BellRing Intermediate Holdings Inc. COMMON STOCK      | CUSIP: 07831C103<br>LEI: 549300S3BOK5CMTS8054 | Long             | EC               | CORP              | US        |    384959 | NS      | $22300674.87  | 0.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Beta Bionics Inc.                             | Beta Bionics Inc. COM                                 | CUSIP: 08659B102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    635906 | NS      | $9258791.36   | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Blackbaud Inc                                 | Blackbaud Inc COM USD0.001                            | CUSIP: 09227Q100<br>LEI: 54930056X3HKFMNG3754 | Long             | EC               | CORP              | US        |    451740 | NS      | $29006225.40  | 0.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Brady Corp                                    | Brady Corp CLASS'A'COM NON-VTG USD0.01                | CUSIP: 104674106<br>LEI: 549300G2LEQOFQC8GY34 | Long             | EC               | CORP              | US        |    184670 | NS      | $12552019.90  | 0.41%             |  |  |  | No            |                  1 | On Loan: No      |
| Bridgebio Pharma Inc                          | Bridgebio Pharma Inc COM USD0.001                     | CUSIP: 10806X102<br>LEI: 54930028YG89VTY2J114 | Long             | EC               | CORP              | US        |    538027 | NS      | $23232005.86  | 0.76%             |  |  |  | No            |                  1 | On Loan: No      |
| Broadridge Financial Solutions Inc.           | Broadridge Financial Solutions Inc. COM USD0.01       | CUSIP: 11133T103<br>LEI: 549300KZDJZQ2YIHRC28 | Long             | EC               | CORP              | US        |    170715 | NS      | $41488866.45  | 1.35%             |  |  |  | No            |                  1 | On Loan: No      |
| CACI International Inc.                       | CACI International Inc. CLASS'A'COM USD0.10           | CUSIP: 127190304<br>LEI: SYRPI2D1O9WRTS2WX210 | Long             | EC               | CORP              | US        |     57748 | NS      | $27528471.60  | 0.89%             |  |  |  | No            |                  1 | On Loan: No      |
| California Resources Corporation              | California Resources Corporation COM STOCK            | CUSIP: 13057Q305<br>LEI: 5493003Q8F0T4F4YMR48 | Long             | EC               | CORP              | US        |    237109 | NS      | $10828768.03  | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| EnerSys                                       | EnerSys COM USD0.01                                   | CUSIP: 29275Y102<br>LEI: 7ZS3DE5PN30BYUJFWP05 | Long             | EC               | CORP              | US        |    173039 | NS      | $14841555.03  | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Enpro Inc                                     | Enpro Inc COM USD0.01                                 | CUSIP: 29355X107<br>LEI: 549300Y5CFT2LKCFDN54 | Long             | EC               | CORP              | US        |    147326 | NS      | $28220295.30  | 0.92%             |  |  |  | No            |                  1 | On Loan: No      |
| Euronet Worldwide, Inc.                       | Euronet Worldwide, Inc. COM USD0.02                   | CUSIP: 298736109<br>LEI: YG3575C4DSHJPA5KET68 | Long             | EC               | CORP              | US        |    359369 | NS      | $36432829.22  | 1.18%             |  |  |  | No            |                  1 | On Loan: No      |
| FirstService Corp.                            | FirstService Corp. COM NPV                            | CUSIP: 33767E202<br>LEI: 5493000XUDIV75BCF118 | Long             | EC               | CORP              | US        |    102526 | NS      | $17903090.12  | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Gildan Activewear Inc.                        | Gildan Activewear Inc. COM NPV                        | CUSIP: 375916103<br>LEI: 549300SB3IBI34M00Z45 | Long             | EC               | CORP              | US        |    674833 | NS      | $33228776.92  | 1.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Glaukos Corp.                                 | Glaukos Corp. COM USD0.001                            | CUSIP: 377322102<br>LEI: 5299004JA1LHE21M6T14 | Long             | EC               | CORP              | US        |    328064 | NS      | $33885730.56  | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Globus Med Inc                                | Globus Med Inc COM USD0.001 CL 'A'                    | CUSIP: 379577208<br>LEI: 5299003M2P4CIK0RF205 | Long             | EC               | CORP              | US        |    629715 | NS      | $37165779.30  | 1.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Halozyme Therapeutics Inc                     | Halozyme Therapeutics Inc COM USD0.001                | CUSIP: 40637H109<br>LEI: 529900242I3SV9AGM753 | Long             | EC               | CORP              | US        |    345118 | NS      | $17953038.36  | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Hamilton Lane Inc                             | Hamilton Lane Inc COM USD0.001 CL A                   | CUSIP: 407497106<br>LEI: 5493006OKN3V1NORM833 | Long             | EC               | CORP              | US        |    122993 | NS      | $17479765.16  | 0.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Healthequity Inc                              | Healthequity Inc COM USD0.0001                        | CUSIP: 42226A107<br>LEI: 529900LRJU1RAFQHM467 | Long             | EC               | CORP              | US        |    224083 | NS      | $23474935.08  | 0.76%             |  |  |  | No            |                  1 | On Loan: No      |
| Travere Therapeutics Inc                      | Travere Therapeutics Inc COM                          | CUSIP: 89422G107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    245008 | NS      | $3626118.40   | 0.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Tyler Technologies Inc.                       | Tyler Technologies Inc. COM USD0.01                   | CUSIP: 902252105<br>LEI: 25490040SMU4Z8LBCW70 | Long             | EC               | CORP              | US        |     58469 | NS      | $34662761.96  | 1.13%             |  |  |  | No            |                  1 | On Loan: No      |
| UL Solutions Inc.                             | UL Solutions Inc. CLASS A COM SHS                     | CUSIP: 903731107<br>LEI: 549300F7CUV5ESKV9P71 | Long             | EC               | CORP              | US        |    244970 | NS      | $17848514.20  | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Valvoline Inc                                 | Valvoline Inc USD0.01                                 | CUSIP: 92047W101<br>LEI: 549300CMHPBEY6VPOT75 | Long             | EC               | CORP              | US        |    891322 | NS      | $33754364.14  | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Vaxcyte Inc                                   | Vaxcyte Inc COM                                       | CUSIP: 92243G108<br>LEI: 254900M7NMHTGASX8D95 | Long             | EC               | CORP              | US        |    495273 | NS      | $16101325.23  | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Verona Pharma Plc                             | Verona Pharma Plc SPONSORED ADS                       | CUSIP: 925050106<br>LEI: 213800EVI6O6J3TIAL06 | Long             |  | CORP              | US        |    260197 | NS      | $24609432.26  | 0.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Inc                                    | Vertex Inc CL A                                       | CUSIP: 92538J106<br>LEI: 549300QMYW171MP1PL50 | Long             | EC               | CORP              | US        |    750407 | NS      | $26515631.35  | 0.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Voyager Technologies Inc.                     | Voyager Technologies Inc. COM CL A                    | CUSIP: 92892B103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    299251 | NS      | $11745601.75  | 0.38%             |  |  |  | No            |                  1 | On Loan: —       |
| Zurn Elkay Water Solutions Corporation        | Zurn Elkay Water Solutions Corporation COM            | CUSIP: 98983L108<br>LEI: 549300AM3633XDFU1Q85 | Long             | EC               | CORP              | US        |   1081198 | NS      | $39539410.86  | 1.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Biohaven Ltd                                  | Biohaven Ltd COM                                      | CUSIP: G1110E107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    530807 | NS      | $7489686.77   | 0.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Avadel Pharmaceuticals PLC                    | Avadel Pharmaceuticals PLC COM SHS                    | CUSIP: G29687103<br>LEI: 549300E27PTSG2RHC762 | Long             | EC               | CORP              | US        |   1480446 | NS      | $13101947.10  | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Gates Industrial Corp PLC                     | Gates Industrial Corp PLC COM USD0.01                 | CUSIP: G39108108<br>LEI: 549300S6K4FWUSB9KM27 | Long             | EC               | CORP              | US        |   1389551 | NS      | $32001359.53  | 1.04%             |  |  |  | No            |                  1 | On Loan: No      |
| AST SpaceMobile Inc.                          | AST SpaceMobile Inc. COM CL A                         | CUSIP: 00217D100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    704711 | NS      | $32931145.03  | 1.07%             |  |  |  | No            |                  1 | On Loan: —       |
| Akero Therapeutics Inc                        | Akero Therapeutics Inc COM USD0.0001                  | CUSIP: 00973Y108<br>LEI: 549300SI3KG74LBE2955 | Long             | EC               | CORP              | US        |    203002 | NS      | $10832186.72  | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| 89bio Inc.                                    | 89bio Inc. COM                                        | CUSIP: 282559103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1148158 | NS      | $11274911.56  | 0.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Ziff Davis Inc                                | Ziff Davis Inc COM USD0.001                           | CUSIP: 48123V102<br>LEI: 5493008OJYGLHD7MXA18 | Long             | EC               | CORP              | US        |    509596 | NS      | $15425470.92  | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Waystar Holding Corp                          | Waystar Holding Corp COM                              | CUSIP: 946784105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    577221 | NS      | $23591022.27  | 0.77%             |  |  |  | No            |                  1 | On Loan: No      |
| WEX Inc                                       | WEX Inc COM USD0.01                                   | CUSIP: 96208T104<br>LEI: T9M5IGROL1TL1G5OV478 | Long             | EC               | CORP              | US        |    151711 | NS      | $22284828.79  | 0.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Xenon Pharmaceuticals Inc                     | Xenon Pharmaceuticals Inc COM NPV                     | CUSIP: 98420N105<br>LEI: 549300XV44Q9Z1MIPQ03 | Long             | EC               | CORP              | US        |    265441 | NS      | $8308303.30   | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| ATS Corporation (Canada)                      | ATS Corporation (Canada) COM                          | CUSIP: 00217Y104<br>LEI: 5493005KP4RP3IU7HQ41 | Long             | EC               | CORP              | CA        |    870308 | NS      | $27759603.73  | 0.90%             |  |  |  | No            |                  1 | On Loan: No      |
| CBIZ Inc.                                     | CBIZ Inc. COM STK USD0.01                             | CUSIP: 124805102<br>LEI: 529900D5X8CFM8O1N813 | Long             | EC               | CORP              | US        |    206867 | NS      | $14834432.57  | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| CECO Environmental Corp.                      | CECO Environmental Corp. COM USD0.01                  | CUSIP: 125141101<br>LEI: 5493002CZCTL4HGLIY91 | Long             | EC               | CORP              | US        |    874514 | NS      | $24757491.34  | 0.80%             |  |  |  | No            |                  1 | On Loan: No      |
| CRA International Inc.                        | CRA International Inc. COM NPV                        | CUSIP: 12618T105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    119955 | NS      | $22475968.35  | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| CSW Industrials Inc.                          | CSW Industrials Inc. COM USD0.01                      | CUSIP: 126402106<br>LEI: 549300SYOEO3RVQ7FB83 | Long             | EC               | CORP              | US        |     81201 | NS      | $23290882.83  | 0.76%             |  |  |  | No            |                  1 | On Loan: No      |
| Caris Life Sciences Inc.                      | Caris Life Sciences Inc. COM                          | CUSIP: 142152107<br>LEI: 549300LX5LO78M5VPY43 | Long             | EC               | CORP              | US        |    644791 | NS      | $17228815.52  | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Casey'S General Stores Inc.                   | Casey'S General Stores Inc. COM NPV                   | CUSIP: 147528103<br>LEI: 549300CAFWSI86V66Q65 | Long             | EC               | CORP              | US        |     99471 | NS      | $50757067.17  | 1.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Centessa Pharmaceuticals plc                  | Centessa Pharmaceuticals plc SPONSORED ADS            | CUSIP: 152309100<br>LEI: 213800GIDAARDSKOI827 | Long             |  | CORP              | US        |    498852 | NS      | $6554915.28   | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Clearwater Analytics Holdings Inc             | Clearwater Analytics Holdings Inc CL A                | CUSIP: 185123106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    699372 | NS      | $15337227.96  | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Colliers International Group Inc              | Colliers International Group Inc SUB VTG COM NPV      | CUSIP: 194693107<br>LEI: D3O8K13PHLEXXD1DT480 | Long             | EC               | CORP              | US        |    134204 | NS      | $17518990.16  | 0.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Consensus Cloud Solutions Inc                 | Consensus Cloud Solutions Inc COM                     | CUSIP: 20848V105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    744357 | NS      | $17164872.42  | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Descartes Systems Group Inc.                  | Descartes Systems Group Inc. COM NPV                  | CUSIP: 249906108<br>LEI: 875500NEPA7JI5EOMN45 | Long             | EC               | CORP              | CA        |    585574 | NS      | $59490637.06  | 1.93%             |  |  |  | No            |                  1 | On Loan: No      |
| Core & Main Inc                               | Core & Main Inc CL A                                  | CUSIP: 21874C102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    833445 | NS      | $50298405.75  | 1.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Computer Modelling                            | Computer Modelling COM NPV                            | CUSIP: 205249105<br>LEI: N/A                  | Long             | EC               | CORP              | CA        |   1841300 | NS      | $9750127.06   | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Crinetics Pharmaceuticals Inc.                | Crinetics Pharmaceuticals Inc. COM USD0.001           | CUSIP: 22663K107<br>LEI: 549300Q1CNFXK5P31D28 | Long             | EC               | CORP              | US        |    289654 | NS      | $8330449.04   | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Disc Medicine Inc                             | Disc Medicine Inc COM                                 | CUSIP: 254604101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    103473 | NS      | $5479930.08   | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Dream Finders Homes Inc                       | Dream Finders Homes Inc COM CL A                      | CUSIP: 26154D100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    584195 | NS      | $14680820.35  | 0.48%             |  |  |  | No            |                  1 | On Loan: —       |
| Doximity Inc                                  | Doximity Inc CL A                                     | CUSIP: 26622P107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    401450 | NS      | $24624943.00  | 0.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Edgewise Therapeutics Inc.                    | Edgewise Therapeutics Inc. COM                        | CUSIP: 28036F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    190678 | NS      | $2499788.58   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Claris Ventures SGR SPA                       | Claris Biotherapeutics Inc                            | CUSIP: N/A<br>LEI: N/A                        | Long             | DBT              | CORP              | US        |    221444 | PA      | $221444.10    | 0.01%             | 2026-07-31      | Fixed         | 8.00%                 | Yes           |                  3 | On Loan: No      |
| Claris Ventures SGR SPA                       | Claris Biotherapeutics Inc - Series A-3               | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |   5023916 | NS      | $481155.51    | 0.02%             |  |  |  | Yes           |                  3 | On Loan: No      |
| CRIMSON CAPITAL                               | Apartment List Inc                                    | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |   2431401 | NS      | $9628347.96   | 0.31%             |  |  |  | Yes           |                  3 | On Loan: No      |
| Constellium SE                                | Constellium SE CL A SHS                               | CUSIP: F21107101<br>LEI: 724500KRJEMC79KAAU28 | Long             | EC               | CORP              | US        |   2177161 | NS      | $28956241.30  | 0.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Cimpress PLC                                  | Cimpress PLC SHS EURO                                 | CUSIP: G2143T103<br>LEI: 549300X1IFD75XISOR81 | Long             | EC               | CORP              | US        |    199517 | NS      | $9377299.00   | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| IntelyCare Inc                                | IntelyCare Inc                                        | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |    384276 | NS      | $972218.28    | 0.03%             |  |  |  | Yes           |                  3 | On Loan: No      |
| KARDIUM SERIES 8 CLASS D PREFERRED SHARES USD | KARDIUM SERIES 8 CLASS D PREFERRED SHARES USD         | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | CA        |   8991217 | NS      | $5819475.29   | 0.19%             |  |  |  | Yes           |                  3 | On Loan: No      |
| Loadsmart Inc                                 | Loadsmart Inc - Series D                              | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |    399891 | NS      | $4498773.75   | 0.15%             |  |  |  | Yes           |                  3 | On Loan: No      |
| Loadsmart Inc                                 | Loadsmart Inc - Series A                              | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |    140312 | NS      | $1578510.00   | 0.05%             |  |  |  | Yes           |                  3 | On Loan: No      |
| IDEAYA Biosciences Inc.                       | IDEAYA Biosciences Inc. COM USD0.0001                 | CUSIP: 45166A102<br>LEI: 549300ULW08F62IJML11 | Long             | EC               | CORP              | US        |    439542 | NS      | $9239172.84   | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Innodata Inc                                  | Innodata Inc COM NEW                                  | CUSIP: 457642205<br>LEI: L9O7MPYIT56T6KBE0R95 | Long             | EC               | CORP              | US        |    519068 | NS      | $26586662.96  | 0.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Insmed Inc                                    | Insmed Inc COM USD0.01                                | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |    318482 | NS      | $32052028.48  | 1.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Inspired Entertainment Inc.                   | Inspired Entertainment Inc. COM USD0.0001             | CUSIP: 45782N108<br>LEI: 549300ZUGYK6NBIU6D69 | Long             | EC               | CORP              | US        |   1275716 | NS      | $10422599.72  | 0.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Janux Therapeutics Inc                        | Janux Therapeutics Inc COM                            | CUSIP: 47103J105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    291055 | NS      | $6723370.50   | 0.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Janus International Group Inc                 | Janus International Group Inc COMMON STOCK            | CUSIP: 47103N106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   2039668 | NS      | $16602897.52  | 0.54%             |  |  |  | No            |                  1 | On Loan: No      |
| LPL Financial Holdings Inc.                   | LPL Financial Holdings Inc. COM USD0.001              | CUSIP: 50212V100<br>LEI: 549300XROQ4Y8G2L7682 | Long             | EC               | CORP              | US        |    160704 | NS      | $60259178.88  | 1.96%             |  |  |  | No            |                  1 | On Loan: No      |
| N/A                                           | OTCOption/CALL American Equity.TRAVERE THEREAP._US    | CUSIP: N/A<br>LEI: N/A                        | N/A              | DE               |  | US        |      1717 | NC      | $301179.49    | 0.01%             |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                           | OTCOption/CALL American Equity.AST SPACEMOBILE A_U    | CUSIP: N/A<br>LEI: N/A                        | N/A              | DE               |  | US        |     -2000 | NC      | $-2046294.60  | -0.07%            |  |  |  | No            |                  2 | On Loan: No      |
| Madrigal Pharmaceuticals Inc                  | Madrigal Pharmaceuticals Inc USD0.0001                | CUSIP: 558868105<br>LEI: 549300CHIMT2EUSNJB60 | Long             | EC               | CORP              | US        |     89583 | NS      | $27111399.12  | 0.88%             |  |  |  | No            |                  1 | On Loan: No      |
| Magnolia Oil & Gas Corporation                | Magnolia Oil & Gas Corporation COM USD0.0001 CLASS A  | CUSIP: 559663109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1290921 | NS      | $29019904.08  | 0.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Mama's Creations, Inc                         | Mama's Creations, Inc COM                             | CUSIP: 56146T103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1375242 | NS      | $11414508.60  | 0.37%             |  |  |  | No            |                  1 | On Loan: No      |
| ICU Medical Inc                               | ICU Medical Inc COM USD0.10                           | CUSIP: 44930G107<br>LEI: 5493003NRW7LS2QZRH60 | Long             | EC               | CORP              | US        |    229343 | NS      | $30307677.45  | 0.99%             |  |  |  | No            |                  1 | On Loan: No      |
| ITT Inc                                       | ITT Inc COM USD1.00                                   | CUSIP: 45073V108<br>LEI: 549300KDSERHTJOXUS80 | Long             | EC               | CORP              | US        |    245239 | NS      | $38460832.37  | 1.25%             |  |  |  | No            |                  1 | On Loan: No      |
| N/A                                           | Sell CAD / Buy USD                                    | CUSIP: N/A<br>LEI: N/A                        | N/A              | DFE              |  | US        |         1 | NC      | $-182777.34   | -0.01%            |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                           | Sell GBP / Buy USD                                    | CUSIP: N/A<br>LEI: N/A                        | N/A              | DFE              |  | US        |         1 | NC      | $-370976.71   | -0.01%            |  |  |  | No            |                  2 | On Loan: No      |
| Lantheus Holdings Inc                         | Lantheus Holdings Inc COM USD0.01                     | CUSIP: 516544103<br>LEI: 5299005HUB5IOJGO7S39 | Long             | EC               | CORP              | US        |    410426 | NS      | $33597472.36  | 1.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Ligand Pharmaceuticals Incorporated           | Ligand Pharmaceuticals Incorporated 'B'COM USD0.001   | CUSIP: 53220K504<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |    285987 | NS      | $32511002.16  | 1.06%             |  |  |  | No            |                  1 | On Loan: No      |
| SS&C Technologies Holdings Inc.               | SS&C Technologies Holdings Inc. COM USD0.01           | CUSIP: 78467J100<br>LEI: 529900POY8H7NPPNKK71 | Long             | EC               | CORP              | US        |    857029 | NS      | $70962001.20  | 2.31%             |  |  |  | No            |                  1 | On Loan: No      |
| SPX Technologies, Inc.                        | SPX Technologies, Inc. COM                            | CUSIP: 78473E103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    341700 | NS      | $57296256.00  | 1.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Sensient Technologies Corp                    | Sensient Technologies Corp COM USD0.10                | CUSIP: 81725T100<br>LEI: CMMZHMFZQG86EI7WZU92 | Long             | EC               | CORP              | US        |    606593 | NS      | $59761542.36  | 1.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Shift4 Payments Inc                           | Shift4 Payments Inc CL A                              | CUSIP: 82452J109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    514610 | NS      | $51002997.10  | 1.66%             |  |  |  | No            |                  1 | On Loan: —       |
| N/A                                           | Sell CAD / Buy USD                                    | CUSIP: N/A<br>LEI: N/A                        | N/A              | DFE              |  | US        |         1 | NC      | $-44282.05    | -0.00%            |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                           | Sell GBP / Buy USD                                    | CUSIP: N/A<br>LEI: N/A                        | N/A              | DFE              |  | US        |         1 | NC      | $-703896.56   | -0.02%            |  |  |  | No            |                  2 | On Loan: No      |
| Loar Holdings Inc                             | Loar Holdings Inc COM SHS                             | CUSIP: 53947R105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    254092 | NS      | $21895107.64  | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| MSA Safety Inc.                               | MSA Safety Inc. COM NPV                               | CUSIP: 553498106<br>LEI: 529900DVA3258XK11O39 | Long             | EC               | CORP              | US        |     92042 | NS      | $15419796.26  | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| N/A                                           | OTCOption/CALL American Equity.AST SPACEMOBILE A_U    | CUSIP: N/A<br>LEI: N/A                        | N/A              | DE               |  | US        |     -1524 | NC      | $-1960139.08  | -0.06%            |  |  |  | No            |                  2 | On Loan: No      |
| MACOM Technology Solutions Holdings Inc.      | MACOM Technology Solutions Holdings Inc. COM USD0.001 | CUSIP: 55405Y100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    121973 | NS      | $17477511.17  | 0.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Mirum Pharmaceuticals Inc.                    | Mirum Pharmaceuticals Inc. COM USD0.0001              | CUSIP: 604749101<br>LEI: 254900YZKR40F7F27K81 | Long             | EC               | CORP              | US        |    480836 | NS      | $24469744.04  | 0.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Monarch Casino & Resort Inc                   | Monarch Casino & Resort Inc COM USD0.01               | CUSIP: 609027107<br>LEI: 549300AK5FF7KY11V997 | Long             | EC               | CORP              | US        |    235315 | NS      | $20340628.60  | 0.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Montrose Environmental Group Inc              | Montrose Environmental Group Inc COM                  | CUSIP: 615111101<br>LEI: 254900ASI8K3LUB8Q958 | Long             | EC               | CORP              | US        |    753767 | NS      | $16499959.63  | 0.54%             |  |  |  | No            |                  1 | On Loan: No      |
| NAPCO Security Technologies Inc.              | NAPCO Security Technologies Inc. COM USD0.01          | CUSIP: 630402105<br>LEI: 529900KV21J4YY9YST76 | Long             | EC               | CORP              | US        |    653368 | NS      | $19398495.92  | 0.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Neogenomics Inc                               | Neogenomics Inc COM NPV                               | CUSIP: 64049M209<br>LEI: 549300KN62PPGHBVXB46 | Long             | EC               | CORP              | US        |   1308983 | NS      | $9568665.73   | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Nice Limited                                  | Nice Limited ADR-EACH REPR 1 ORD ILS1                 | CUSIP: 653656108<br>LEI: 254900YTY4EF5Z4W0A51 | Long             |  | CORP              | US        |    107061 | NS      | $18083673.51  | 0.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Novanta Inc                                   | Novanta Inc COM NPV                                   | CUSIP: 67000B104<br>LEI: 549300NBPHPTUPTS8070 | Long             | EC               | CORP              | US        |    167390 | NS      | $21581592.70  | 0.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Manchester United PLC                         | Manchester United PLC COM USD0.0005 CL 'A'            | CUSIP: G5784H106<br>LEI: 529900GWGZPE83MJOV59 | Long             | EC               | CORP              | US        |    568938 | NS      | $10132785.78  | 0.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Steris PLC                                    | Steris PLC ORD USD0.001                               | CUSIP: G8473T100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     76418 | NS      | $18357131.96  | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| OSI System Inc.                               | OSI System Inc. COM NPV                               | CUSIP: 671044105<br>LEI: DDX3MPX1Y8YD30050X33 | Long             | EC               | CORP              | US        |    300838 | NS      | $67646432.68  | 2.20%             |  |  |  | No            |                  1 | On Loan: No      |
| ON Semiconductor Corp.                        | ON Semiconductor Corp. COM USD0.01                    | CUSIP: 682189105<br>LEI: ZV20P4CNJVT8V1ZGJ064 | Long             | EC               | CORP              | US        |    380287 | NS      | $19930841.67  | 0.65%             |  |  |  | No            |                  1 | On Loan: No      |
| OmniAb Inc.                                   | OmniAb Inc. USD0.0001 A (USD12.5 VESTING)             | CUSIP: 68218J202<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    104942 | NS      | $72158.12     | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| OmniAb Inc.                                   | OmniAb Inc. USD0.0001 A (USD15 VESTING)               | CUSIP: 68218J301<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    104942 | NS      | $62251.59     | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| JANUS CAPITAL GROUP INC                       | Janus Henderson Cash Liquidity Fund LLC               | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | PF                | US        |  64977483 | NS      | $64990478.59  | 2.11%             |  |  |  | No            |                  2 | On Loan: No      |
| Kinaxis Inc                                   | Kinaxis Inc COM NPV                                   | CUSIP: 49448Q109<br>LEI: 5299009VAZ14K7PFUQ15 | Long             | EC               | CORP              | CA        |    132201 | NS      | $19663151.09  | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| N/A                                           | Sell CAD / Buy USD                                    | CUSIP: N/A<br>LEI: N/A                        | N/A              | DFE              |  | US        |         1 | NC      | $-18931.07    | -0.00%            |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                           | Sell USD / Buy GBP                                    | CUSIP: N/A<br>LEI: N/A                        | N/A              | DFE              |  | US        |         1 | NC      | $1467.64      | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                           | Sell CAD / Buy USD                                    | CUSIP: N/A<br>LEI: N/A                        | N/A              | DFE              |  | US        |         1 | NC      | $-24331.33    | -0.00%            |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                           | Sell GBP / Buy USD                                    | CUSIP: N/A<br>LEI: N/A                        | N/A              | DFE              |  | US        |         1 | NC      | $-377434.74   | -0.01%            |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                           | Sell CAD / Buy USD                                    | CUSIP: N/A<br>LEI: N/A                        | N/A              | DFE              |  | US        |         1 | NC      | $-49434.07    | -0.00%            |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                           | Sell GBP / Buy USD                                    | CUSIP: N/A<br>LEI: N/A                        | N/A              | DFE              |  | US        |         1 | NC      | $-460715.18   | -0.01%            |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                           | Sell CAD / Buy USD                                    | CUSIP: N/A<br>LEI: N/A                        | N/A              | DFE              |  | US        |         1 | NC      | $-227894.14   | -0.01%            |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                           | Sell GBP / Buy USD                                    | CUSIP: N/A<br>LEI: N/A                        | N/A              | DFE              |  | US        |         1 | NC      | $-359895.03   | -0.01%            |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                           | Sell USD / Buy CAD                                    | CUSIP: N/A<br>LEI: N/A                        | N/A              | DFE              |  | US        |         1 | NC      | $58589.19     | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                           | Sell USD / Buy GBP                                    | CUSIP: N/A<br>LEI: N/A                        | N/A              | DFE              |  | US        |         1 | NC      | $295059.76    | 0.01%             |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                           | Sell CAD / Buy USD                                    | CUSIP: N/A<br>LEI: N/A                        | N/A              | DFE              |  | US        |         1 | NC      | $-18919.90    | -0.00%            |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                           | Sell USD / Buy GBP                                    | CUSIP: N/A<br>LEI: N/A                        | N/A              | DFE              |  | US        |         1 | NC      | $543338.46    | 0.02%             |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                           | Sell CAD / Buy USD                                    | CUSIP: N/A<br>LEI: N/A                        | N/A              | DFE              |  | US        |         1 | NC      | $-36865.64    | -0.00%            |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                           | Sell GBP / Buy USD                                    | CUSIP: N/A<br>LEI: N/A                        | N/A              | DFE              |  | US        |         1 | NC      | $-16477.38    | -0.00%            |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                           | Sell USD / Buy GBP                                    | CUSIP: N/A<br>LEI: N/A                        | N/A              | DFE              |  | US        |         1 | NC      | $1481.64      | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| Kornit Digital Limited                        | Kornit Digital Limited ORD ILS0.01                    | CUSIP: M6372Q113<br>LEI: 5299006DPCQWP3VTFK34 | Long             | EC               | CORP              | US        |    699477 | NS      | $13926587.07  | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Nova Ltd                                      | Nova Ltd ILS0.01                                      | CUSIP: M7516K103<br>LEI: 529900B2DSWE5V3SC292 | Long             | EC               | CORP              | US        |     47000 | NS      | $12934400.00  | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Oddity Tech Ltd.                              | Oddity Tech Ltd. SHS CL A                             | CUSIP: M7518J104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    516155 | NS      | $38954217.85  | 1.27%             |  |  |  | No            |                  1 | On Loan: No      |
| PDF Solutions Inc                             | PDF Solutions Inc COM USD0.00015                      | CUSIP: 693282105<br>LEI: 549300GMSP6MROFBI160 | Long             | EC               | CORP              | US        |    742419 | NS      | $15872918.22  | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| PTC Therapeutics, Inc.                        | PTC Therapeutics, Inc. COM USD0.001                   | CUSIP: 69366J200<br>LEI: 549300UJLWOIWFDGB318 | Long             | EC               | CORP              | US        |    322303 | NS      | $15741278.52  | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Paylocity Holding Corporation                 | Paylocity Holding Corporation COM USD0.001            | CUSIP: 70438V106<br>LEI: 549300VH75FTB4DIEE07 | Long             | EC               | CORP              | US        |    211858 | NS      | $38386551.02  | 1.25%             |  |  |  | No            |                  1 | On Loan: No      |
| Perimeter Solutions Inc.                      | Perimeter Solutions Inc. COMMON STOCK                 | CUSIP: 71385M107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   2545253 | NS      | $35429921.76  | 1.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Portillos Inc.                                | Portillos Inc. COM CL A                               | CUSIP: 73642K106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1164718 | NS      | $13592259.06  | 0.44%             |  |  |  | No            |                  1 | On Loan: —       |
| Procore Technologies Inc                      | Procore Technologies Inc COM                          | CUSIP: 74275K108<br>LEI: 5493005PTWY0RHYRAH22 | Long             | EC               | CORP              | US        |    207418 | NS      | $14191539.56  | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| RLI Corp                                      | RLI Corp COM USD1.00                                  | CUSIP: 749607107<br>LEI: 529900AMTJE5ECN9PS55 | Long             | EC               | CORP              | US        |    247321 | NS      | $17861522.62  | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Rentokil Initial PLC                          | Rentokil Initial PLC SPON ADR REP 5 ORD GBP0.01       | CUSIP: 760125104<br>LEI: 549300VN4WV7Z6T14K68 | Long             |  | CORP              | US        |   1754424 | NS      | $42106176.00  | 1.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Repay Holdings Corporation                    | Repay Holdings Corporation COM USD0.0001 CL A         | CUSIP: 76029L100<br>LEI: 2549006EJ42T73ZKUI98 | Long             | EC               | CORP              | US        |    634949 | NS      | $3060454.18   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Revolution Medicines Inc                      | Revolution Medicines Inc COM                          | CUSIP: 76155X100<br>LEI: 549300JU3X0LBCQ65892 | Long             | EC               | CORP              | US        |    469585 | NS      | $17276032.15  | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Simulations Plus Inc.                         | Simulations Plus Inc. COM USD0.001                    | CUSIP: 829214105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    759259 | NS      | $13249069.55  | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Soleno Therapeutics Inc                       | Soleno Therapeutics Inc COM                           | CUSIP: 834203309<br>LEI: 5493003LCY77N7FXK844 | Long             | EC               | CORP              | US        |    210080 | NS      | $17600502.40  | 0.57%             |  |  |  | No            |                  1 | On Loan: No      |
| StandardAero Inc.                             | StandardAero Inc. COM                                 | CUSIP: 85423L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    763957 | NS      | $24179239.05  | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Sterling Infrastructure Inc                   | Sterling Infrastructure Inc COM USD0.01               | CUSIP: 859241101<br>LEI: 549300RZIK6K1215XU51 | Long             | EC               | CORP              | US        |    126781 | NS      | $29252180.13  | 0.95%             |  |  |  | No            |                  1 | On Loan: No      |
| Stride Inc                                    | Stride Inc COM                                        | CUSIP: 86333M108<br>LEI: 254900BRWS3AFONWU277 | Long             | EC               | CORP              | US        |    580358 | NS      | $84262178.02  | 2.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Structure Therapeutics Inc                    | Structure Therapeutics Inc SPONSORED ADS              | CUSIP: 86366E106<br>LEI: N/A                  | Long             |  | CORP              | US        |    262274 | NS      | $5439562.76   | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Thor Industries Inc.                          | Thor Industries Inc. COM USD0.10                      | CUSIP: 885160101<br>LEI: 254900XZO1228PDSG060 | Long             | EC               | CORP              | US        |    110793 | NS      | $9839526.33   | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Janus Henderson Cash Collateral Fund          | Janus Henderson Cash Collateral Fund                  | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | PF                | US        |  54716853 | NS      | $54716853.00  | 1.78%             |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                           | Royal Bank of Canada                                  | CUSIP: N/A<br>LEI: N/A                        | Long             | STIV             | CORP              | US        |  12571496 | PA      | $12571496.00  | 0.41%             | 2025-07-01      | Fixed         | 4.31%                 | No            |                  2 | On Loan: No      |

### Signature

**Date Signed:** 2025-08-14

**Name of Applicant:** JANUS INVESTMENT FUND

**Signature:** JESPER NERGAARD

**Name of Signer:** JESPER NERGAARD

**Title:** VP, CFO, TREASURER, AND PRINCIPAL ACCOUNTING OFFICER